How often does Regenxbio move more than the options market prices?

2 of the last 8 reports moved at least as far as the implied move.

RGNXNasdaqBiological Products, (No Diagnostic Substances)

Regenxbio Inc. (RGNX) earnings date, market-implied expected move, and options open interest by expiry

7.38

−0.33 · −4.28%

Regular session15:32 ET

Open8.01Volume854,955Mkt cap$503.7MEPS-3.79

Day7.22 – 8.1118%52-wk5.46 – 16.1918%

RGNX

Regenxbio Inc.

OpenVolumeMkt capP/EEPSDiv yield

Day – 52-wk –

Expected move

No implied move.

Expected move

Inputs

Next report

Mar 4

before open · in 119 days

est.Q4 FY26

Calendar

Next report

Last report

Nov 5

before open

confirmedNov 4 closethin chain

Implied vs realized

Linked news

1dQURE · customeruniQure hit with amended securities class action over Huntington's data
1dRARE · customerUltragenyx posts net loss of $118 million, revenue $173 million for Q3
2dABBV · customerAbbVie posts net earnings $4,220 million, diluted EPS $2.37 for quarter

News

Largest filed tie

13F top-10 QoQ

−0.31%

shares held · 10 largest managers

13F · Jun 30 '26128d lag

167 managers

Top fund weight

0.22%

RGNX weight · XBI

N-PORTJun 30 '26

4 funds

Last reportshaded = implied▲▼ = realized× = |realized| ÷ implied

Regenxbio (RGNX) is expected to report on Mar 4 before open (estimated date).

Implied vs realized

8 reports

2 of 8≥ implied

avg implied: ±21.6%
avg realized: ±10.2%

Nov 6 '24Nov 6 '24confirmed±17.3%▲+18.66%×1.08

Mar 13 '25Mar 13 '25confirmed±17.6%▲+2.60%×0.15

May 12 '25May 12 '25confirmed±10.8%▲+2.63%×0.24

Aug 7 '25Aug 7 '25confirmed±17.3%▼−4.01%×0.23

Q3 FY25Nov 6 '25confirmed±16.9%▼−3.79%×0.22

Q1 FY26Mar 5 '26confirmed±42.1%▼−4.60%×0.11

May 14 '26May 14 '26confirmed±32.5%▼−37.80%×1.16

Q2 FY26Aug 6 '26confirmed±18.2%▲+7.43%×0.41

quarterimplied−45%0+45%realized×

Q2 FY26±18.2%▲+7.43%×0.41

May '26±32.5%

Shaded = implied · tick ▲▼ = realized · × = |realized| ÷ impliedSource: options EOD · implied at prior close · realized close to close

Implied vs realized

Positioning

OI · 4 expiries · Nov 4 close

0.30OI · 4 expiries · Nov 4 closeP/C open interest · Apr 16 · first expiry after the report

PUTS · chgexpiry · days · P/CCALLS · chgP/C

201+3%Nov 2015d0.141,4020%0.14

30%Dec 1843d0.01430+43%0.01

983−1%Jan 1571d0.293,337−3%0.29

report · Mar 4 · before open · est.

4740%Apr 16162d1,562+2%

ExpiryPutsCallsP/C

Nov 2015d201+3%1,4020%0.14

Dec 1843d30%430+43%0.01

Jan 1571d983−1%3,337−3%0.29

report · Mar 4 · before open · est.

Hatched = puts · solid = calls · bars scaled per expiry · chg = OI vs prior sessionSource: options EOD

Positioning

Linked exposure

No implied move.

Linked exposure

Revenue flow

as filedQ3 FY26

−444.64%as filednet margin · revenue −91.52% QoQ · −69.19% YoY

Revenue$9M−91.52%

Gross profit$9M100.00%−91.52%

Operating income−$36M−387.84%−221.43%

Pre-tax income−$41M−279.39%

Net income−$41M−444.64%−279.39%

Cost of revenue$0—

Operating expenses$45M−43.25%

Other expense−$5M+20.60%

Source: SEC filings · standardized · QE Sep 30 '26 · bars = % of revenue

Revenue flow

Intraday

15m bars

Hatch = extended hours · ▯ up · ▮ downSource: market data · 15:30 ET

Intraday

Event sensitivity

FOMC ×1.44· ±5.3% vs ±3.7% · 24 releases

eventrelease day|move|up · n×base

FOMCrate decision±5.3%12 of 24×1.44

GDPgross domestic product±3.7%14 of 20×0.99

CPROFcorporate profits±3.4%9 of 12×0.93

NFPjobs report±3.2%4 of 10×0.86

PCEpersonal income & outlays±3.0%12 of 20×0.83

CPIconsumer prices±2.8%3 of 11×0.76

PPIproducer prices±2.5%4 of 11×0.69

Bar = avg |move| to ±6% · tick = ±3.7% avg day · ×base = |move| ÷ ±3.7% · min 6 releases

Earnings history

EPS -0.62 · consensus —

Quarter	Reported	EPS	Consensus
Q3 FY26	—	-0.62	—
Q2 FY26	Aug 6 '26 · confirmed	0.43	—
Q1 FY26	Mar 5 '26 · confirmed	-1.72	—
Q3 FY25	Nov 6 '25 · confirmed	-1.20	—

Source: filed financials

Methodology

ties · implied moves · holdersMethod